nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—migraine—Prednisone—systemic scleroderma	0.69	1	CpDpCtD
Tizanidine—CYP1A2—Pentoxifylline—systemic scleroderma	0.0351	0.512	CbGbCtD
Tizanidine—CYP1A2—Leflunomide—systemic scleroderma	0.0335	0.488	CbGbCtD
Tizanidine—Fatigue—Leflunomide—systemic scleroderma	0.000138	0.00057	CcSEcCtD
Tizanidine—Oedema—Lisinopril—systemic scleroderma	0.000137	0.000568	CcSEcCtD
Tizanidine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000137	0.000568	CcSEcCtD
Tizanidine—Pruritus—Captopril—systemic scleroderma	0.000137	0.000568	CcSEcCtD
Tizanidine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000137	0.000567	CcSEcCtD
Tizanidine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000137	0.000566	CcSEcCtD
Tizanidine—Constipation—Leflunomide—systemic scleroderma	0.000136	0.000566	CcSEcCtD
Tizanidine—Infection—Lisinopril—systemic scleroderma	0.000136	0.000565	CcSEcCtD
Tizanidine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000564	CcSEcCtD
Tizanidine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000136	0.000563	CcSEcCtD
Tizanidine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000135	0.000561	CcSEcCtD
Tizanidine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000135	0.000561	CcSEcCtD
Tizanidine—Shock—Lisinopril—systemic scleroderma	0.000135	0.000559	CcSEcCtD
Tizanidine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000134	0.000556	CcSEcCtD
Tizanidine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000134	0.000555	CcSEcCtD
Tizanidine—Tachycardia—Lisinopril—systemic scleroderma	0.000134	0.000555	CcSEcCtD
Tizanidine—Abdominal pain—Azathioprine—systemic scleroderma	0.000134	0.000554	CcSEcCtD
Tizanidine—Body temperature increased—Azathioprine—systemic scleroderma	0.000134	0.000554	CcSEcCtD
Tizanidine—Skin disorder—Lisinopril—systemic scleroderma	0.000133	0.000552	CcSEcCtD
Tizanidine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000133	0.00055	CcSEcCtD
Tizanidine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000133	0.000549	CcSEcCtD
Tizanidine—Diarrhoea—Captopril—systemic scleroderma	0.000132	0.000549	CcSEcCtD
Tizanidine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000548	CcSEcCtD
Tizanidine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000547	CcSEcCtD
Tizanidine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000546	CcSEcCtD
Tizanidine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000132	0.000545	CcSEcCtD
Tizanidine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000131	0.000544	CcSEcCtD
Tizanidine—Mood swings—Methotrexate—systemic scleroderma	0.000131	0.000544	CcSEcCtD
Tizanidine—Nausea—Mometasone—systemic scleroderma	0.000131	0.000543	CcSEcCtD
Tizanidine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000131	0.000541	CcSEcCtD
Tizanidine—Constipation—Mycophenolic acid—systemic scleroderma	0.00013	0.00054	CcSEcCtD
Tizanidine—Weight decreased—Prednisone—systemic scleroderma	0.00013	0.000537	CcSEcCtD
Tizanidine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000129	0.000536	CcSEcCtD
Tizanidine—Hyperglycaemia—Prednisone—systemic scleroderma	0.000129	0.000535	CcSEcCtD
Tizanidine—Hypotension—Lisinopril—systemic scleroderma	0.000128	0.000531	CcSEcCtD
Tizanidine—Dizziness—Captopril—systemic scleroderma	0.000128	0.000531	CcSEcCtD
Tizanidine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000128	0.00053	CcSEcCtD
Tizanidine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000128	0.000529	CcSEcCtD
Tizanidine—Depression—Prednisone—systemic scleroderma	0.000127	0.000528	CcSEcCtD
Tizanidine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000127	0.000527	CcSEcCtD
Tizanidine—Urticaria—Leflunomide—systemic scleroderma	0.000127	0.000525	CcSEcCtD
Tizanidine—Abdominal pain—Leflunomide—systemic scleroderma	0.000126	0.000523	CcSEcCtD
Tizanidine—Body temperature increased—Leflunomide—systemic scleroderma	0.000126	0.000523	CcSEcCtD
Tizanidine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000126	0.000522	CcSEcCtD
Tizanidine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000125	0.00052	CcSEcCtD
Tizanidine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000125	0.000519	CcSEcCtD
Tizanidine—Myocardial infarction—Prednisone—systemic scleroderma	0.000125	0.000519	CcSEcCtD
Tizanidine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000125	0.000519	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000125	0.000518	CcSEcCtD
Tizanidine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000125	0.000518	CcSEcCtD
Tizanidine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000125	0.000516	CcSEcCtD
Tizanidine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000125	0.000516	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000124	0.000516	CcSEcCtD
Tizanidine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000124	0.000513	CcSEcCtD
Tizanidine—Paraesthesia—Lisinopril—systemic scleroderma	0.000123	0.00051	CcSEcCtD
Tizanidine—Vomiting—Captopril—systemic scleroderma	0.000123	0.00051	CcSEcCtD
Tizanidine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000508	CcSEcCtD
Tizanidine—Dyspnoea—Lisinopril—systemic scleroderma	0.000122	0.000507	CcSEcCtD
Tizanidine—Rash—Captopril—systemic scleroderma	0.000122	0.000506	CcSEcCtD
Tizanidine—Dermatitis—Captopril—systemic scleroderma	0.000122	0.000506	CcSEcCtD
Tizanidine—Somnolence—Lisinopril—systemic scleroderma	0.000122	0.000505	CcSEcCtD
Tizanidine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000121	0.000502	CcSEcCtD
Tizanidine—Dyspepsia—Lisinopril—systemic scleroderma	0.000121	0.0005	CcSEcCtD
Tizanidine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00012	0.000499	CcSEcCtD
Tizanidine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00012	0.000499	CcSEcCtD
Tizanidine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00012	0.000498	CcSEcCtD
Tizanidine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00012	0.000498	CcSEcCtD
Tizanidine—Asthma—Methotrexate—systemic scleroderma	0.00012	0.000496	CcSEcCtD
Tizanidine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000495	CcSEcCtD
Tizanidine—Fatigue—Lisinopril—systemic scleroderma	0.000118	0.00049	CcSEcCtD
Tizanidine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000118	0.00049	CcSEcCtD
Tizanidine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000118	0.000488	CcSEcCtD
Tizanidine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000118	0.000488	CcSEcCtD
Tizanidine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000118	0.000487	CcSEcCtD
Tizanidine—Constipation—Lisinopril—systemic scleroderma	0.000117	0.000486	CcSEcCtD
Tizanidine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000117	0.000486	CcSEcCtD
Tizanidine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000117	0.000484	CcSEcCtD
Tizanidine—Bradycardia—Prednisone—systemic scleroderma	0.000117	0.000484	CcSEcCtD
Tizanidine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000116	0.000481	CcSEcCtD
Tizanidine—Diarrhoea—Azathioprine—systemic scleroderma	0.000116	0.000479	CcSEcCtD
Tizanidine—Haemoglobin—Prednisone—systemic scleroderma	0.000115	0.000478	CcSEcCtD
Tizanidine—Nausea—Captopril—systemic scleroderma	0.000115	0.000477	CcSEcCtD
Tizanidine—Haemorrhage—Prednisone—systemic scleroderma	0.000115	0.000475	CcSEcCtD
Tizanidine—Asthenia—Leflunomide—systemic scleroderma	0.000115	0.000475	CcSEcCtD
Tizanidine—Hallucination—Prednisone—systemic scleroderma	0.000114	0.000473	CcSEcCtD
Tizanidine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000113	0.000468	CcSEcCtD
Tizanidine—Pruritus—Leflunomide—systemic scleroderma	0.000113	0.000468	CcSEcCtD
Tizanidine—Connective tissue disorder—Prednisone—systemic scleroderma	0.000113	0.000467	CcSEcCtD
Tizanidine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000465	CcSEcCtD
Tizanidine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000112	0.000465	CcSEcCtD
Tizanidine—Dizziness—Azathioprine—systemic scleroderma	0.000112	0.000463	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000109	0.000454	CcSEcCtD
Tizanidine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000109	0.000453	CcSEcCtD
Tizanidine—Diarrhoea—Leflunomide—systemic scleroderma	0.000109	0.000453	CcSEcCtD
Tizanidine—Urticaria—Lisinopril—systemic scleroderma	0.000109	0.000452	CcSEcCtD
Tizanidine—Abdominal pain—Lisinopril—systemic scleroderma	0.000108	0.000449	CcSEcCtD
Tizanidine—Body temperature increased—Lisinopril—systemic scleroderma	0.000108	0.000449	CcSEcCtD
Tizanidine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000447	CcSEcCtD
Tizanidine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000108	0.000446	CcSEcCtD
Tizanidine—Vomiting—Azathioprine—systemic scleroderma	0.000107	0.000445	CcSEcCtD
Tizanidine—Pneumonia—Methotrexate—systemic scleroderma	0.000107	0.000445	CcSEcCtD
Tizanidine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000107	0.000444	CcSEcCtD
Tizanidine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000107	0.000443	CcSEcCtD
Tizanidine—Drowsiness—Methotrexate—systemic scleroderma	0.000107	0.000442	CcSEcCtD
Tizanidine—Rash—Azathioprine—systemic scleroderma	0.000107	0.000442	CcSEcCtD
Tizanidine—Dermatitis—Azathioprine—systemic scleroderma	0.000106	0.000441	CcSEcCtD
Tizanidine—Depression—Methotrexate—systemic scleroderma	0.000106	0.000441	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000106	0.000439	CcSEcCtD
Tizanidine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000106	0.000438	CcSEcCtD
Tizanidine—Dizziness—Leflunomide—systemic scleroderma	0.000106	0.000437	CcSEcCtD
Tizanidine—Renal failure—Methotrexate—systemic scleroderma	0.000105	0.000435	CcSEcCtD
Tizanidine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000104	0.000432	CcSEcCtD
Tizanidine—Angiopathy—Prednisone—systemic scleroderma	0.000104	0.000431	CcSEcCtD
Tizanidine—Conjunctivitis—Methotrexate—systemic scleroderma	0.000104	0.00043	CcSEcCtD
Tizanidine—Immune system disorder—Prednisone—systemic scleroderma	0.000104	0.000429	CcSEcCtD
Tizanidine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000426	CcSEcCtD
Tizanidine—Arrhythmia—Prednisone—systemic scleroderma	0.000102	0.000424	CcSEcCtD
Tizanidine—Sweating—Methotrexate—systemic scleroderma	0.000102	0.000424	CcSEcCtD
Tizanidine—Haematuria—Methotrexate—systemic scleroderma	0.000102	0.000422	CcSEcCtD
Tizanidine—Vomiting—Leflunomide—systemic scleroderma	0.000101	0.000421	CcSEcCtD
Tizanidine—Alopecia—Prednisone—systemic scleroderma	0.000101	0.00042	CcSEcCtD
Tizanidine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000101	0.000419	CcSEcCtD
Tizanidine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000101	0.000418	CcSEcCtD
Tizanidine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000101	0.000417	CcSEcCtD
Tizanidine—Rash—Leflunomide—systemic scleroderma	0.000101	0.000417	CcSEcCtD
Tizanidine—Dermatitis—Leflunomide—systemic scleroderma	0.000101	0.000417	CcSEcCtD
Tizanidine—Mental disorder—Prednisone—systemic scleroderma	0.0001	0.000416	CcSEcCtD
Tizanidine—Nausea—Azathioprine—systemic scleroderma	0.0001	0.000416	CcSEcCtD
Tizanidine—Agranulocytosis—Methotrexate—systemic scleroderma	9.96e-05	0.000413	CcSEcCtD
Tizanidine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	9.9e-05	0.00041	CcSEcCtD
Tizanidine—Asthenia—Lisinopril—systemic scleroderma	9.84e-05	0.000408	CcSEcCtD
Tizanidine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	9.83e-05	0.000407	CcSEcCtD
Tizanidine—Pruritus—Lisinopril—systemic scleroderma	9.7e-05	0.000402	CcSEcCtD
Tizanidine—Vomiting—Mycophenolic acid—systemic scleroderma	9.68e-05	0.000401	CcSEcCtD
Tizanidine—Haemoglobin—Methotrexate—systemic scleroderma	9.63e-05	0.000399	CcSEcCtD
Tizanidine—Rash—Mycophenolic acid—systemic scleroderma	9.6e-05	0.000398	CcSEcCtD
Tizanidine—Dermatitis—Mycophenolic acid—systemic scleroderma	9.59e-05	0.000397	CcSEcCtD
Tizanidine—Hepatitis—Methotrexate—systemic scleroderma	9.58e-05	0.000397	CcSEcCtD
Tizanidine—Haemorrhage—Methotrexate—systemic scleroderma	9.58e-05	0.000397	CcSEcCtD
Tizanidine—Urticaria—Mycophenolate mofetil—systemic scleroderma	9.55e-05	0.000396	CcSEcCtD
Tizanidine—Pharyngitis—Methotrexate—systemic scleroderma	9.51e-05	0.000394	CcSEcCtD
Tizanidine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	9.5e-05	0.000394	CcSEcCtD
Tizanidine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	9.5e-05	0.000394	CcSEcCtD
Tizanidine—Nausea—Leflunomide—systemic scleroderma	9.48e-05	0.000393	CcSEcCtD
Tizanidine—Urinary tract disorder—Methotrexate—systemic scleroderma	9.46e-05	0.000392	CcSEcCtD
Tizanidine—Vision blurred—Prednisone—systemic scleroderma	9.41e-05	0.00039	CcSEcCtD
Tizanidine—Urethral disorder—Methotrexate—systemic scleroderma	9.39e-05	0.000389	CcSEcCtD
Tizanidine—Diarrhoea—Lisinopril—systemic scleroderma	9.38e-05	0.000389	CcSEcCtD
Tizanidine—Ill-defined disorder—Prednisone—systemic scleroderma	9.26e-05	0.000384	CcSEcCtD
Tizanidine—Anaemia—Prednisone—systemic scleroderma	9.22e-05	0.000382	CcSEcCtD
Tizanidine—Agitation—Prednisone—systemic scleroderma	9.17e-05	0.00038	CcSEcCtD
Tizanidine—Dizziness—Lisinopril—systemic scleroderma	9.07e-05	0.000376	CcSEcCtD
Tizanidine—Erythema multiforme—Methotrexate—systemic scleroderma	9.06e-05	0.000375	CcSEcCtD
Tizanidine—Nausea—Mycophenolic acid—systemic scleroderma	9.04e-05	0.000375	CcSEcCtD
Tizanidine—Malaise—Prednisone—systemic scleroderma	9e-05	0.000373	CcSEcCtD
Tizanidine—Vertigo—Prednisone—systemic scleroderma	8.97e-05	0.000372	CcSEcCtD
Tizanidine—Syncope—Prednisone—systemic scleroderma	8.95e-05	0.000371	CcSEcCtD
Tizanidine—Tinnitus—Methotrexate—systemic scleroderma	8.93e-05	0.00037	CcSEcCtD
Tizanidine—Cardiac disorder—Methotrexate—systemic scleroderma	8.89e-05	0.000369	CcSEcCtD
Tizanidine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	8.85e-05	0.000367	CcSEcCtD
Tizanidine—Loss of consciousness—Prednisone—systemic scleroderma	8.77e-05	0.000364	CcSEcCtD
Tizanidine—Vomiting—Lisinopril—systemic scleroderma	8.72e-05	0.000361	CcSEcCtD
Tizanidine—Angiopathy—Methotrexate—systemic scleroderma	8.69e-05	0.00036	CcSEcCtD
Tizanidine—Immune system disorder—Methotrexate—systemic scleroderma	8.65e-05	0.000359	CcSEcCtD
Tizanidine—Rash—Lisinopril—systemic scleroderma	8.65e-05	0.000358	CcSEcCtD
Tizanidine—Convulsion—Prednisone—systemic scleroderma	8.65e-05	0.000358	CcSEcCtD
Tizanidine—Dermatitis—Lisinopril—systemic scleroderma	8.64e-05	0.000358	CcSEcCtD
Tizanidine—Mediastinal disorder—Methotrexate—systemic scleroderma	8.63e-05	0.000358	CcSEcCtD
Tizanidine—Asthenia—Mycophenolate mofetil—systemic scleroderma	8.62e-05	0.000357	CcSEcCtD
Tizanidine—Hypertension—Prednisone—systemic scleroderma	8.62e-05	0.000357	CcSEcCtD
Tizanidine—Pruritus—Mycophenolate mofetil—systemic scleroderma	8.5e-05	0.000352	CcSEcCtD
Tizanidine—Arthralgia—Prednisone—systemic scleroderma	8.5e-05	0.000352	CcSEcCtD
Tizanidine—Anxiety—Prednisone—systemic scleroderma	8.47e-05	0.000351	CcSEcCtD
Tizanidine—Alopecia—Methotrexate—systemic scleroderma	8.47e-05	0.000351	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	8.44e-05	0.00035	CcSEcCtD
Tizanidine—Discomfort—Prednisone—systemic scleroderma	8.39e-05	0.000348	CcSEcCtD
Tizanidine—Mental disorder—Methotrexate—systemic scleroderma	8.39e-05	0.000348	CcSEcCtD
Tizanidine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	8.22e-05	0.000341	CcSEcCtD
Tizanidine—Nausea—Lisinopril—systemic scleroderma	8.15e-05	0.000338	CcSEcCtD
Tizanidine—Oedema—Prednisone—systemic scleroderma	8.14e-05	0.000338	CcSEcCtD
Tizanidine—Anaphylactic shock—Prednisone—systemic scleroderma	8.14e-05	0.000338	CcSEcCtD
Tizanidine—Infection—Prednisone—systemic scleroderma	8.09e-05	0.000335	CcSEcCtD
Tizanidine—Back pain—Methotrexate—systemic scleroderma	8.07e-05	0.000334	CcSEcCtD
Tizanidine—Shock—Prednisone—systemic scleroderma	8.01e-05	0.000332	CcSEcCtD
Tizanidine—Nervous system disorder—Prednisone—systemic scleroderma	7.99e-05	0.000331	CcSEcCtD
Tizanidine—Tachycardia—Prednisone—systemic scleroderma	7.95e-05	0.000329	CcSEcCtD
Tizanidine—Dizziness—Mycophenolate mofetil—systemic scleroderma	7.95e-05	0.000329	CcSEcCtD
Tizanidine—Skin disorder—Prednisone—systemic scleroderma	7.91e-05	0.000328	CcSEcCtD
Tizanidine—Hyperhidrosis—Prednisone—systemic scleroderma	7.87e-05	0.000326	CcSEcCtD
Tizanidine—Vision blurred—Methotrexate—systemic scleroderma	7.86e-05	0.000326	CcSEcCtD
Tizanidine—Ill-defined disorder—Methotrexate—systemic scleroderma	7.74e-05	0.000321	CcSEcCtD
Tizanidine—Anaemia—Methotrexate—systemic scleroderma	7.71e-05	0.000319	CcSEcCtD
Tizanidine—Vomiting—Mycophenolate mofetil—systemic scleroderma	7.64e-05	0.000317	CcSEcCtD
Tizanidine—Rash—Mycophenolate mofetil—systemic scleroderma	7.58e-05	0.000314	CcSEcCtD
Tizanidine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	7.57e-05	0.000314	CcSEcCtD
Tizanidine—Malaise—Methotrexate—systemic scleroderma	7.52e-05	0.000312	CcSEcCtD
Tizanidine—Vertigo—Methotrexate—systemic scleroderma	7.49e-05	0.000311	CcSEcCtD
Tizanidine—Leukopenia—Methotrexate—systemic scleroderma	7.47e-05	0.000309	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	7.42e-05	0.000308	CcSEcCtD
Tizanidine—Paraesthesia—Prednisone—systemic scleroderma	7.31e-05	0.000303	CcSEcCtD
Tizanidine—Convulsion—Methotrexate—systemic scleroderma	7.23e-05	0.000299	CcSEcCtD
Tizanidine—Dyspepsia—Prednisone—systemic scleroderma	7.17e-05	0.000297	CcSEcCtD
Tizanidine—Nausea—Mycophenolate mofetil—systemic scleroderma	7.14e-05	0.000296	CcSEcCtD
Tizanidine—Arthralgia—Methotrexate—systemic scleroderma	7.1e-05	0.000294	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	7.05e-05	0.000292	CcSEcCtD
Tizanidine—Fatigue—Prednisone—systemic scleroderma	7.02e-05	0.000291	CcSEcCtD
Tizanidine—Discomfort—Methotrexate—systemic scleroderma	7.02e-05	0.000291	CcSEcCtD
Tizanidine—Constipation—Prednisone—systemic scleroderma	6.97e-05	0.000289	CcSEcCtD
Tizanidine—Confusional state—Methotrexate—systemic scleroderma	6.86e-05	0.000284	CcSEcCtD
Tizanidine—Anaphylactic shock—Methotrexate—systemic scleroderma	6.81e-05	0.000282	CcSEcCtD
Tizanidine—Infection—Methotrexate—systemic scleroderma	6.76e-05	0.00028	CcSEcCtD
Tizanidine—Feeling abnormal—Prednisone—systemic scleroderma	6.71e-05	0.000278	CcSEcCtD
Tizanidine—Nervous system disorder—Methotrexate—systemic scleroderma	6.68e-05	0.000277	CcSEcCtD
Tizanidine—Thrombocytopenia—Methotrexate—systemic scleroderma	6.66e-05	0.000276	CcSEcCtD
Tizanidine—Gastrointestinal pain—Prednisone—systemic scleroderma	6.66e-05	0.000276	CcSEcCtD
Tizanidine—Skin disorder—Methotrexate—systemic scleroderma	6.61e-05	0.000274	CcSEcCtD
Tizanidine—Hyperhidrosis—Methotrexate—systemic scleroderma	6.58e-05	0.000273	CcSEcCtD
Tizanidine—Urticaria—Prednisone—systemic scleroderma	6.47e-05	0.000268	CcSEcCtD
Tizanidine—Abdominal pain—Prednisone—systemic scleroderma	6.44e-05	0.000267	CcSEcCtD
Tizanidine—Body temperature increased—Prednisone—systemic scleroderma	6.44e-05	0.000267	CcSEcCtD
Tizanidine—Hypotension—Methotrexate—systemic scleroderma	6.36e-05	0.000264	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	6.2e-05	0.000257	CcSEcCtD
Tizanidine—Paraesthesia—Methotrexate—systemic scleroderma	6.11e-05	0.000253	CcSEcCtD
Tizanidine—Dyspnoea—Methotrexate—systemic scleroderma	6.07e-05	0.000252	CcSEcCtD
Tizanidine—Somnolence—Methotrexate—systemic scleroderma	6.05e-05	0.000251	CcSEcCtD
Tizanidine—Hypersensitivity—Prednisone—systemic scleroderma	6e-05	0.000249	CcSEcCtD
Tizanidine—Dyspepsia—Methotrexate—systemic scleroderma	5.99e-05	0.000248	CcSEcCtD
Tizanidine—Fatigue—Methotrexate—systemic scleroderma	5.87e-05	0.000243	CcSEcCtD
Tizanidine—Asthenia—Prednisone—systemic scleroderma	5.84e-05	0.000242	CcSEcCtD
Tizanidine—Pruritus—Prednisone—systemic scleroderma	5.76e-05	0.000239	CcSEcCtD
Tizanidine—Feeling abnormal—Methotrexate—systemic scleroderma	5.61e-05	0.000232	CcSEcCtD
Tizanidine—Diarrhoea—Prednisone—systemic scleroderma	5.57e-05	0.000231	CcSEcCtD
Tizanidine—Gastrointestinal pain—Methotrexate—systemic scleroderma	5.57e-05	0.000231	CcSEcCtD
Tizanidine—Urticaria—Methotrexate—systemic scleroderma	5.41e-05	0.000224	CcSEcCtD
Tizanidine—Dizziness—Prednisone—systemic scleroderma	5.39e-05	0.000223	CcSEcCtD
Tizanidine—Abdominal pain—Methotrexate—systemic scleroderma	5.38e-05	0.000223	CcSEcCtD
Tizanidine—Body temperature increased—Methotrexate—systemic scleroderma	5.38e-05	0.000223	CcSEcCtD
Tizanidine—Vomiting—Prednisone—systemic scleroderma	5.18e-05	0.000215	CcSEcCtD
Tizanidine—Rash—Prednisone—systemic scleroderma	5.14e-05	0.000213	CcSEcCtD
Tizanidine—Dermatitis—Prednisone—systemic scleroderma	5.13e-05	0.000213	CcSEcCtD
Tizanidine—Hypersensitivity—Methotrexate—systemic scleroderma	5.02e-05	0.000208	CcSEcCtD
Tizanidine—Asthenia—Methotrexate—systemic scleroderma	4.88e-05	0.000202	CcSEcCtD
Tizanidine—Nausea—Prednisone—systemic scleroderma	4.84e-05	0.0002	CcSEcCtD
Tizanidine—Pruritus—Methotrexate—systemic scleroderma	4.82e-05	0.0002	CcSEcCtD
Tizanidine—Diarrhoea—Methotrexate—systemic scleroderma	4.66e-05	0.000193	CcSEcCtD
Tizanidine—Dizziness—Methotrexate—systemic scleroderma	4.5e-05	0.000187	CcSEcCtD
Tizanidine—Vomiting—Methotrexate—systemic scleroderma	4.33e-05	0.000179	CcSEcCtD
Tizanidine—Rash—Methotrexate—systemic scleroderma	4.29e-05	0.000178	CcSEcCtD
Tizanidine—Dermatitis—Methotrexate—systemic scleroderma	4.29e-05	0.000178	CcSEcCtD
Tizanidine—Nausea—Methotrexate—systemic scleroderma	4.04e-05	0.000168	CcSEcCtD
